Amster Rothstein and Ebenstein, LLP - Intellectual Property Law

Tony Taldone Scientific Advisor

Print
Direct 212 336 8188
Main 212 336 8000
Fax 212 336 8001
E-mail   

90 Park Avenue, 21st Floor
New York, NY 10016
 
Tony is an expert organic and medicinal chemist and group leader with more than 12 years of experience in drug discovery and development and translational research with skills/expertise in all aspects of small-molecule drug discovery including preclinical and clinical development.

He has a strong research history focused on the development of novel anticancer agents, the generation of IP and in obtaining research funding.

Tony assists patent attorneys in drafting claims in patent applications, in preparing detailed chemical procedures for the synthesis and identification of chemical compounds and in preparing data tables of biological activity.


Education
  • Memorial Sloan Kettering Institute for Cancer Research, New York, NY, Postdoctoral Research Fellow/Associate, 2008-2013
  • St. John’s University, Ph.D., Medicinal Chemistry, 2008
  • St. John’s University, MS, Organic Chemistry, 2000
  • St. John’s University, BS., Chemistry, 1999
Honor & Awards
  • Department of Defense, U.S. Army Postdoctoral Fellowship, 2010-2013 “Preclinical Development of Tumor-Specific Hsp70 Inhibitors in Breast Cancer”
  • Komen for the Cure Postdoctoral Fellowship, 2009-2012 “Pre-clinical development of tumor specific Hsp70 inhibitors in breast cancer”
Professional Affiliations
  • American Chemical Society
  • American Association for Cancer Research
  • Peer reviewer for Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Current Organic Synthesis, MedChemComm, Expert Opinion on Drug Discovery, Recent Patents on Anti-Cancer Drug Discovery, Clinical Cancer Research, Tumor Biology, Letters in Organic Chemistry, Letters in Drug Design and Discovery, BioMed Research International, Journal of Sulfur Chemistry, Combinatorial Chemistry & High Throughput Screening, Journal of Heterocyclic Chemistry
Linkedin AREnet Access
©2007-2021 Amster Rothstein & Ebenstein LLP.    All rights reserved. | Disclaimer